Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.06%66.42B | 72.50%256.01B | 116.01%63.22B | 28.85%148.41B | 112.09%58.75B | 0.60%32.22B | 2.25%28.17B | 4.90%29.27B | 1.50%115.18B | 6.23%27.7B |
| Cost of revenue | 5.62%47.08B | 108.88%180.8B | 201.90%44.57B | 44.89%86.56B | 187.10%40.97B | -0.89%16.8B | -0.65%14.03B | 2.49%14.76B | 1.39%59.74B | 2.46%14.27B |
| Gross profit | 3.73%19.35B | 21.60%75.21B | 28.59%18.65B | 11.57%61.85B | 32.39%17.78B | 2.27%15.42B | 5.32%14.15B | 7.46%14.5B | 1.61%55.44B | 10.56%13.43B |
| Operating expense | 0.61%17.51B | 20.48%68.35B | 29.84%17.4B | 8.90%56.73B | 26.70%16.95B | -1.92%13.2B | 3.58%13.18B | 6.93%13.4B | 3.39%52.09B | 3.26%13.38B |
| Operating profit | 47.16%1.84B | 33.93%6.87B | 13.44%1.25B | 53.15%5.13B | 1,442.59%833M | 37.08%2.22B | 36.62%970M | 14.45%1.1B | -19.77%3.35B | 106.69%54M |
| Net non-operating interest income (expenses) | -31.21%-206M | -216.17%-743M | -361.76%-157M | -88.00%-235M | -294.12%-134M | 0.00%-33M | -9.68%-34M | -25.93%-34M | -34.41%-125M | 19.05%-34M |
| Non-operating interest income | 150.00%5M | 2,200.00%23M | --2M | --1M | --1M | --0 | --0 | --0 | --0 | --0 |
| Non-operating interest expense | 32.70%211M | 224.58%766M | 367.65%159M | 88.80%236M | 297.06%135M | 0.00%33M | 9.68%34M | 25.93%34M | 34.41%125M | -19.05%34M |
| Net investment income | 88.33%-7M | 91.80%-5M | -3,100.00%-60M | -662.50%-61M | -671.43%-54M | 2M | 42.86%-8M | -16.67%-7M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -3,800.00%-37M | -702.70%-223M | -97.37%1M | 107.41%37M | 36.55%-342M | 155.00%102M | 239M | 38M | -5,444.44%-499M | -26,850.00%-539M |
| Income from associates and other participating interests | 247.06%50M | 2,175.00%498M | -152.31%-34M | 78.76%-24M | -290.91%-189M | 761.90%139M | 72.14%-39M | 227.45%65M | -653.33%-113M | 257.14%99M |
| Special income (charges) | 58M | -97.98%41M | 0 | 14,564.29%2.03B | -106.54%-14M | |||||
| Less:Restructuring and mergern&acquisition | ---- | 87.26%-439M | ---- | ---3.45B | ---- | ---- | ---- | ---- | --0 | ---- |
| Less:Other special charges | ---58M | --177M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | -84.46%221M | ---- | 10,057.14%1.42B | ---- | ---- | ---- | ---- | 55.56%14M | ---- |
| Other non-operating income (expenses) | 138.71%12M | 127.02%127M | -234.78%-31M | -812.12%-470M | -2,413.64%-509M | -86.89%8M | 119.51%8M | -4.17%23M | -35.29%66M | -4.35%22M |
| Income before tax | 76.65%1.71B | 2.52%6.56B | -19.06%968M | 141.25%6.4B | 485.27%1.62B | 46.25%2.44B | 129.32%1.14B | 31.72%1.2B | -39.15%2.65B | 47.83%-421M |
| Income tax | 29.98%802M | 9.21%3.1B | 61.94%617M | 136.56%2.83B | 1,742.67%1.38B | 35.25%729M | 35.18%342M | 15.11%381M | -29.53%1.2B | 135.05%75M |
| Net income | 159.14%907M | -2.81%3.46B | -57.06%350M | 145.12%3.56B | 148.48%240M | 51.51%1.71B | 226.53%800M | 41.49%815M | -45.28%1.45B | 16.67%-495M |
| Net income continuous operations | 158.69%908M | -2.81%3.46B | -56.93%351M | 145.12%3.56B | 148.39%240M | 51.51%1.71B | 226.53%800M | 41.25%815M | -45.30%1.45B | 16.36%-496M |
| Noncontrolling interests | 15,700.00%156M | 68.20%-173M | 50.00%-1M | -54.11%-544M | -136.94%-853M | 24.68%96M | 458.33%215M | 80.00%-2M | -411.59%-353M | -1,284.62%-360M |
| Net income attributable to the company | 113.07%750M | -11.44%3.64B | -56.92%352M | 127.34%4.11B | 909.63%1.09B | 53.71%1.61B | 91.48%584M | 39.18%817M | -33.74%1.81B | 76.19%-135M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 113.07%750M | -11.44%3.64B | -56.92%352M | 127.34%4.11B | 909.63%1.09B | 53.71%1.61B | 91.48%584M | 39.18%817M | -33.74%1.81B | 76.19%-135M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -3.31%21.62 | -8.23%103.13 | 0.00%22.36 | 127.26%112.38 | 908.38%29.91 | 53.64%44.14 | 91.26%15.97 | 39.14%22.36 | -33.75%49.45 | 76.14%-3.7 |
| Diluted earnings per share | -3.31%21.62 | -8.23%103.13 | 0.00%22.36 | 127.26%112.38 | 908.05%29.8977 | 53.68%44.14 | 91.42%15.97 | 39.14%22.36 | -33.71%49.45 | 76.14%-3.7 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |